Epigenetics of lung cancer

Transl Res. 2015 Jan;165(1):74-90. doi: 10.1016/j.trsl.2014.03.001. Epub 2014 Mar 12.

Abstract

Lung cancer is the leading cause of cancer-related mortality in the United States. Epigenetic alterations, including DNA methylation, histone modifications, and noncoding RNA expression, have been reported widely in the literature to play a major role in the genesis of lung cancer. The goal of this review is to summarize the common epigenetic changes associated with lung cancer to give some clarity to its etiology, and to provide an overview of the potential translational applications of these changes, including applications for early detection, diagnosis, prognostication, and therapeutics.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics
  • Clinical Trials as Topic
  • DNA Methylation
  • Epigenesis, Genetic*
  • Female
  • Genes, Tumor Suppressor
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / etiology
  • Lung Neoplasms / genetics*
  • Male
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Prognosis
  • Risk Factors
  • Translational Research, Biomedical

Substances

  • Biomarkers, Tumor
  • MicroRNAs